TNF and benign prostatic hyperplasia: This analysis indicated that treatment with specific therapeutics, namely TNF-antagonists but not methotrexate, significantly decreased (odds ratio = 0.79; p = 0.033) the likelihood of a BPH diagnosis compared to patients not taking these drugs (Table 1).